Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nammi Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
IDEAYA Biosciences
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Actuate Therapeutics Inc.
Conjupro Biotherapeutics, Inc.
NRG Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
National Cancer Institute (NCI)
SystImmune Inc.
Pfizer
Mayo Clinic
M.D. Anderson Cancer Center
Filamon LTD
PMV Pharmaceuticals, Inc
Mayo Clinic
Washington University School of Medicine
M.D. Anderson Cancer Center
Xencor, Inc.
Memorial Sloan Kettering Cancer Center
ViroMissile, Inc.
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Florida
Tizona Therapeutics, Inc
Essen Biotech
Clasp Therapeutics, Inc.
OHSU Knight Cancer Institute
Baylor College of Medicine
University of Colorado, Denver
Centre Paul Strauss
Roswell Park Cancer Institute
Institut Bergonié
Daiichi Sankyo
Boehringer Ingelheim
University of Michigan Rogel Cancer Center
Kidney Cancer Research Bureau
HealthPartners Institute
Institut Bergonié
Second Life Therapeutics
University of Kansas Medical Center
Phrontline Biopharma
Medical College of Wisconsin
Novartis
Var2 Pharmaceuticals